SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-018354
Filing Date
2019-06-27
Accepted
2019-06-27 16:15:37
Documents
2
Period of Report
2019-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1578
2 EX-24 DOCUMENT attachment1.htm EX-24 5019
  Complete submission text file 0000899243-19-018354.txt   8153
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Krasnow Ronald A. (Reporting) CIK: 0001591469 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38356 | Film No.: 19925475